Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Eyenovia Inc (EYEN)

Eyenovia Inc (EYEN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 55,571
  • Shares Outstanding, K 19,776
  • Annual Sales, $ 0 K
  • Annual Income, $ -21,160 K
  • 60-Month Beta 2.33
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 4.51

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/20
See More
  • Average Estimate -0.21
  • Number of Estimates 2
  • High Estimate -0.17
  • Low Estimate -0.25
  • Prior Year -0.44
  • Growth Rate Est. (year over year) +52.27%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.70 +4.44%
on 07/07/20
3.64 -22.53%
on 06/17/20
-0.38 (-11.88%)
since 06/09/20
3-Month
2.66 +6.02%
on 04/13/20
3.85 -26.75%
on 05/12/20
+0.05 (+1.81%)
since 04/09/20
52-Week
1.11 +154.05%
on 03/19/20
5.06 -44.26%
on 09/19/19
-0.78 (-21.67%)
since 07/09/19

Most Recent Stories

More News
Eyenovia Resumes Recruitment of Phase III CHAPERONE Study for Progressive Myopia

Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose array print (MAP(TM)) therapeutics, today announced that the Company has resumed...

EYEN : 2.82 (+0.36%)
Eyenovia, Inc. Announces Adjournment of 2020 Annual Meeting of Stockholders to June 30, 2020 and Change to a Virtual Meeting Format

Eyenovia, Inc. (NASDAQ: EYEN) a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its patented piezo-print delivery technology, today announced...

EYEN : 2.82 (+0.36%)
Eyenovia Announces Intention to Adjourn 2020 Annual Meeting of Stockholders to June 30, 2020 and Change to a Virtual Meeting Format

Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its patented piezo-print delivery technology, today announced...

EYEN : 2.82 (+0.36%)
Eyenovia Reports First Quarter 2020 Financial Results

Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its patented piezo-print delivery technology, today announced...

EYEN : 2.82 (+0.36%)
Healthcare Integrated Technologies, Inc. Engages Intellectual Property Counsel

Healthcare Integrated Technologies, Inc. ("HITC") is pleased to announce the addition of Jurgen Vollrath as its outside counsel for Intellectual Property ("IP") to its growing team of professionals. Mr....

EYEN : 2.82 (+0.36%)
Eyenovia Announces Conference Call and Webcast for First Quarter 2020 Financial Results

Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its patented piezo-print delivery technology, today announced...

EYEN : 2.82 (+0.36%)
Will Eyenovia Continue to Surge Higher?

As of late, it has definitely been a great time to be an investor Eyenovia

EYEN : 2.82 (+0.36%)
Eyenovia Reports Fourth Quarter and Full Year 2019 Financial Results

Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its patented piezo-print delivery technology, today announced...

EYEN : 2.82 (+0.36%)
Eyenovia, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / March 25, 2020 / Eyenovia, Inc. (NASDAQ:EYEN) will be discussing their earnings results in their 2019 Fourth Quarter Earnings call to be held on March 25, 2020 at 4:30 PM Eastern...

EYEN : 2.82 (+0.36%)
Eyenovia, Inc. Announces Closing of Approximately $6.0 Million Private Placement

Eyenovia, Inc. (NASDAQ:EYEN) a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its patented piezo-print technology, announced that today it...

EYEN : 2.82 (+0.36%)
NHLD : 1.9700 (-0.51%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Trade EYEN with:

Business Summary

Eyenovia, Inc. is a clinical stage biopharmaceutical company which engages in developing therapeutics for the treatment of prominent eye diseases primarily in the United States. Its product portfolio includes MicroProst, MicroStat, MicroTears and MicroPine which are in clinical stage. Eyenovia, Inc....

See More

Key Turning Points

2nd Resistance Point 2.99
1st Resistance Point 2.90
Last Price 2.82
1st Support Level 2.74
2nd Support Level 2.67

See More

52-Week High 5.06
Fibonacci 61.8% 3.55
Fibonacci 50% 3.08
Last Price 2.82
Fibonacci 38.2% 2.62
52-Week Low 1.11

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar